Targeting cyclooxygenase-2 in human neoplasia
Top Cited Papers
- 1 December 2003
- journal article
- review article
- Published by Elsevier in Cancer Cell
- Vol. 4 (6), 431-436
- https://doi.org/10.1016/s1535-6108(03)00310-6
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Prostaglandin E2 Regulates Cell Migration via the Intracellular Activation of the Epidermal Growth Factor ReceptorJournal of Biological Chemistry, 2003
- Regulation of Cyclooxgenase-2 mRNA Stability by TaxanesJournal of Biological Chemistry, 2003
- Regulation of Cyclooxygenase-2 Expression by the Translational Silencer TIA-1The Journal of Experimental Medicine, 2003
- Celecoxib, a Selective Cyclo-Oxygenase-2 Inhibitor, Enhances the Response to Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2003
- Host Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor GrowthThe Journal of Experimental Medicine, 2003
- Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast CancerJournal of Biological Chemistry, 2002
- Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cellsJournal of Clinical Investigation, 2001
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Host cyclooxygenase-2 modulates carcinoma growthJournal of Clinical Investigation, 2000
- Cyclooxygenases: Structural, Cellular, and Molecular BiologyAnnual Review of Biochemistry, 2000